Skip To Content

Study ID: COG ANBL1232

Title:

Utilizing Response- and Biology-Based Risk Factors to Guide Therapy in Patients with Non-High-Risk Neuroblastoma

Location:
Sioux Falls Region
Principal Investigator:
Kayelyn Wagner, MD
Disease:
NBL (Neuroblastoma)
Stage:
Phase III
Status:
Active - Open to Accrual

For more information, call or email Bismarck Clinical Research at (701) 323-5760, Fargo and Bemidji Clinical Research at (701) 234-5890, or Sioux Falls Clinical Research at (605) 328-1368.